Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $298.33 | 8 | 97.4% |
| Education | $7.83 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $165.26 | 3 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $115.99 | 5 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $24.91 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $140.92 | 2 | IDORSIA PHARMACEUTICALS US INC ($140.92) |
| 2022 | $116.32 | 5 | Sunovion Pharmaceuticals Inc. ($67.07) |
| 2021 | $48.92 | 2 | Sunovion Pharmaceuticals Inc. ($48.92) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: INSOMNIA | ||||||
| 04/06/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $120.71 | General |
| Category: INSOMNIA | ||||||
| 11/17/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: INSOMNIA | ||||||
| 11/03/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: CNS | ||||||
| 07/19/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: CNS | ||||||
| 03/15/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Central Nervous System | ||||||
| 02/08/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Education | In-kind items and services | $7.83 | General |
| Category: CNS | ||||||
| 11/16/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: CNS | ||||||
| 08/31/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 78 | 555 | $87,620 | $36,573 |
| 2022 | 3 | 72 | 630 | $105,470 | $47,343 |
| 2021 | 2 | 56 | 612 | $103,215 | $47,703 |
| 2020 | 3 | 78 | 691 | $94,765 | $41,738 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 28 | 282 | $56,400 | $20,370 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 112 | $15,120 | $8,430 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 161 | $16,100 | $7,773 | 48.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 30 | 326 | $65,200 | $24,411 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 282 | $38,070 | $21,819 | 57.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 22 | $2,200 | $1,113 | 50.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 28 | 327 | $65,400 | $24,721 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 285 | $37,815 | $22,981 | 60.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 33 | 345 | $69,000 | $26,859 | 38.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 33 | 312 | $21,840 | $12,591 | 57.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 34 | $3,925 | $2,288 | 58.3% |
About Dr. Alan Corman, MD
Dr. Alan Corman, MD is a Psychiatry healthcare provider based in Arlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043247273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Corman, MD has received a total of $306.16 in payments from pharmaceutical and medical device companies, with $140.92 received in 2023. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($298.33).
As a Medicare-enrolled provider, Corman has provided services to 284 Medicare beneficiaries, totaling 2,488 services with total Medicare billing of $173,357. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Arlington, MA
- Active Since 06/26/2006
- Last Updated 12/21/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043247273
Products in Payments
- QUVIVIQ (Drug) $165.26
- LATUDA (Drug) $115.99
- AUSTEDO (Drug) $24.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Arlington
Dr. Wasiq Zaidi, Md, MD
Psychiatry — Payments: $152,592
Dr. Robert Mims, M.d, M.D
Psychiatry — Payments: $8,421
Randolph Frank, Md, MD
Psychiatry — Payments: $8,387
Jamuna Raju, M.d, M.D
Psychiatry — Payments: $6,923
Dr. Shahzad Rahman, Md, MD
Psychiatry — Payments: $5,925
Betsy Cooper, M.d, M.D
Psychiatry — Payments: $5,187